Table 3. Overall rebleeding rate and rebleeding rate of the most frequent bleeding etiologies on day 3 and day 7.
Total cohort | Monotherapy | Salvage therapy | P value | |
Technical success, n (%) | 51/52 (98.1) | 23/23 (100) | 28/29 (96,6) | 1 |
Overall rebleeding on Day 3, n (%) | 22/51 (43.1) | 9/23 (39.1) | 13/29 (44.8) | 0.78 |
Overall rebleeding on Day 7, n (%) | 25/51 (49) | 10/23 (43.5) | 15/29 (51.7) | 0.58 |
Rebleeding from peptic ulcer on Day 3, n (%) | 8/18 (44.4) | 3/5 (60) | 5/13 (38.5) | 0.61 |
Rebleeding from peptic ulcer on Day 7, n (%) | 10/18 (55.5) | 3/5 (60) | 7/13 (54) | 1 |
Rebleeding from post-interventional ulcer on Day 3, n (%) | 7/14 (50) | 1/4 (25) | 6/10 (60) | 0.56 |
Rebleeding from post-interventional ulcer on Day 7, n (%) | 8/14 (57.1) | 2/4 (50) | 6/10 (60) | 1 |
Rebleeding from tumor bleeding on Day 3, n (%) | 2/10 (20) | 2/7 (28.6) | 0/3 | 1 |
Rebleeding from tumor bleeding on Day 7, n (%) | 2/10 (20) | 2/7 (28.6) | 0/3 | 1 |